Here, we present a Mass Spectrometry Imaging protocol for sequential metabolite, N-linked glycan, and tryptic peptide detection in formalin-fixed, paraffin-embedded tissue samples.
Method Article
EHSeeley@mdanderson.org
Corresponding Authors: Erin H. Seeley <EHSeeley@mdanderson.org>
Here, we present a Mass Spectrometry Imaging protocol for sequential metabolite, N-linked glycan, and tryptic peptide detection in formalin-fixed, paraffin-embedded tissue samples.
Tissues are complex cellular environments, made up of a vast array of cell types and biomolecules all interacting with each other to carry out the functions of the organ. Traditionally, techniques for the analysis of biomolecules such as metabolites, glycans, and proteins involved the homogenization of tissue, destroying all spatial information. These traditional methods inhibited the complete understanding of complex intra- and extracellular molecular interactions. Mass Spectrometry Imaging (MSI), on the other hand, not only preserves the spatial information of biomolecules in tissue but also allows for multiple classes of analytes to be detected from the same tissue section through sequential analysis at a near-single-cell resolution. This enables us to derive a more complete picture of molecular interactions across different classes of biomolecules. The protocol presented here outlines the steps for performing mass spectrometry imaging of metabolites, N-linked glycans, and tryptic peptides sequentially from the same tissue section at a 20 µm resolution. Conscientious consideration of the order in which the classes of analytes are imaged, along with careful handling of the sections to ensure integrity, allows for multiple high-quality images to be collected from the same section. These data can subsequently be integrated with other spatial omics data (transcriptomics, immunohistochemistry, etc.) collected from serial sections, where the same cell can be analyzed in these adjacent sections.
Mass Spectrometry Imaging (MSI) is a powerful technique that allows for the detection and visualization of hundreds to thousands of biomolecules from thin tissue sections, without the need for a priori knowledge of the exact molecules present in the tissue, making it an excellent tool for biomarker discovery1. While several types of MSI are used by different labs, including Desorption ElectroSpray Ionization (DESI)2,3, Infrared Matrix Assisted Laser Desorption ElectroSpray Ionization (IR-MALDESI)4, and Secondary Ion Mass Spectrometry (SIMS)5, Matrix Assisted Laser Desorption/Ionization (MALDI) remains the most commonly used and most versatile. Most classes of biomolecules can be detected by MSI by tailoring the sample preparation, including washing/pretreatment of the tissue, enzymatic digestion, and the matrix/solvent used6,7. MALDI MSI has been used for the detection of metabolites, lipids, glycans, proteins, and proteolytic peptides.
MSI studies have been used in a variety of clinical and preclinical studies to better understand disease mechanisms8,9, improve cancer grading and staging10,11, predict treatment outcome12, improve diagnosis13, and determine molecular tumor margins14, among others. Most of these studies have focused on the detection of only a single class of analytes. However, it is often of interest to analyze more than one class of biomolecules from the same sample. Traditionally, that has been performed with serial sections of tissues. But more recently, examples have been shown of sequentially analyzing multiple analyte classes from the same tissue section. For example, Yagnik et al. have demonstrated lipid imaging of frozen tissue followed by MALDI Immunohistochemistry from the same section for cell type classification15. Clift et al. have shown sequential application of PNGaseF, Collagenase, and Trypsin to formalin-fixed, paraffin-embedded (FFPE) tissue sections for imaging of N-linked glycans, extracellular matrix proteins, and general proteins, respectively16. Escobar et al. demonstrated the sequential analysis of N-linked glycans, O-GlcNAc, and tryptic peptides from the same section of frozen tissue17. These types of experiments are accomplished through careful experimental planning to analyze the most easily lost analytes first, followed by those that are more stable in the tissue. In many cases, the washes that are used to remove unwanted classes of molecules help enhance other classes of molecules6, a property that can be taken advantage of, where each wash that removes the previously applied matrix also helps to enhance the signal of the next class of analytes to be imaged.
Recently, we published a workflow for the sequential analysis of metabolites, N-linked glycans, and tryptic peptides from the same section of FFPE ovarian cancer tissue18. Here, we present the detailed workflow for the analysis of these three classes of biomolecules from the same tissue section; an overview of the protocol is detailed in Figure 1. To our knowledge, this is first protocol describing in detail this workflow for sequential imaging from FFPE tissue. Briefly, tissue sections are dewaxed with xylene before coating with 1,5-diaminonaphthalene matrix (10 mg/mL in 50% acetonitrile) for negative ion mode metabolite imaging. The matrix is then removed, the sections rehydrated, and antigen-retrieved, before being sprayed with PNGase F (0.1 µg/µL in ammonium bicarbonate) to release N-linked glycans in situ. After incubation, the sections are coated with α-cyano-4-hydroxycinnamic acid (CHCA) (10 mg/mL in 70% acetonitrile, 0.1% trifluoroacetic acid) matrix and imaged in positive ion mode. Matrix is then removed again, rehydration and antigen retrieval repeated, and the sections are sprayed with trypsin (0.075 µg/µL in ammonium bicarbonate) and incubated before being again coated with CHCA (10 mg/mL in 70% acetonitrile, 0.1% trifluoroacetic acid) matrix and imaged in positive ion mode. All solutions should be made fresh, immediately before use, and if at all possible, the experiments should be carried out over 3 consecutive days. If delays are encountered, sections should be stored in a -80 °C freezer under desiccation.
This protocol uses formalin-fixed paraffin-embedded (FFPE) tissues collected from previously untreated patients undergoing primary cytoreductive surgery for high-grade serous ovarian carcinoma. All clinical data were obtained from the ovarian cancer repository of the Department of Gynecologic Oncology and Reproductive Medicine under protocols approved by the University of Texas MD Anderson's Institutional Review Board. Written informed consent from the patients was obtained by front desk personnel, and the studies were conducted in accordance with recognized ethical guidelines.
1. Metabolite imaging sample preparation
NOTE: This protocol assumes that sections of formalin-fixed, paraffin-embedded tissue (4 µm thickness) have already been mounted on glass microscope slides, as clinical samples must generally be sectioned within a clinical pathology core by histotechnicians. As the work presented here is performed on the referenced TOF instrument, the orthogonal TOF measurement alleviates the need for conductive slides traditionally used in MSI experiments. The use of standard microscope slides is also more conducive to standard workflows in clinical pathology labs, as well as enabling the use of archival tissue already on slides.
2. Metabolite imaging data collection
3. Sample preparation for N-linked glycan imaging
4. N -Linked glycan imaging data collection
5. Sample preparation for tryptic peptide imaging
6. Tryptic peptide imaging data collection
7. Histological staining
NOTE: There are several methods for hematoxylin and eosin available. Presented here is a modified Carazzi Method frequently used in this lab.
8. Data visualization
NOTE: There is extensive analysis that can be done with SCiLS Lab that is beyond the scope of this protocol. Here, we will just describe basic file creation, data visualization, and searching of peaks against databases for putative identification.
The completion of this protocol should result in three robust MSI datasets from the same section of tissue. In the visualization of the full spectrum of the metabolite data, the spectrum will be heavily dominated by matrix peaks at m/z 157 and 315. This is normal for FFPE tissue. Many metabolite and fatty acid signals will be observed by zooming in on the m/z ranges <155 and between 250 and 300. Figure 3 shows examples of the full spectrum and zoomed ranges highlighting the complex metabolite spectra obtained from the tissue. Typically, between 700 and 900 metabolite peaks are observed from FFPE tissue sections in negative mode with this sample preparation.
PNGaseF digestion should result in the detection of ~2-300 glycan peaks in the tissue. Peaks originating from glycans in the m/z range 1,000-2,000, should have decimal masses of 0.3-0.7 due to their atomic composition. This decimal mass helps to distinguish glycans from matrix clusters that may be observed with this sample preparation. Figure 4A shows examples of robust glycan signal with abundant peaks, especially m/z 1,127.55, 1,325.58, 1,663.58, and 1,809.64, while Figure 4B shows a spectrum with poor glycan signal. This spectrum is dominated by matrix cluster peaks with decimal masses of 0.0-0.2, likely the result of poor efficiency of the PNGaseF digestion on tissue, possibly a result of incomplete washing of the tissue or the presence of small molecule inhibitors in the tissue.
On tissue, tryptic digestion should result in the detection of 800-1,000 peptide peaks in the average mass spectrum. Figure 5A displays a robust average peptide spectrum from a successful sequential imaging experiment. Hundreds of peptides are detected across the analyzed m/z range with high intensity. In contrast, Figure 5B shows a relatively unsuccessful tryptic digest average spectrum. In this case, fewer peptides are detected in the higher m/z range. This is most likely attributed to errors in spraying, in active enzyme, or incomplete washing of the tissue to remove interfering molecules.
Since all three datasets were collected from the same piece of tissue, they can be easily co-registered using the SCiLS Ion Image Mapper to visualize co- and differential localization of molecules belonging to different classes. Figure 6 shows an example of a glycan (green), a metabolite (taurine, red), and a tryptic peptide (blue), both separately (left) and combined (right). This type of data co-registration enables a deeper understanding of the spatial biology occurring in complex tissue samples.

Figure 1: General outline of FFPE SeqMSI protocol.
After tissue slides are mounted, they are (A) marked for fiducials and deparaffinized to be prepared for optical image scanning. (B) Subsequently, they are sprayed with DAN for metabolite imaging, which is (C) removed before proceeding with PNGaseF and digestion incubation. (D) Slides are then prepared for Glycan imaging in which they are sprayed with CHCA matrix and imaged; (E) the CHCA matrix is subsequently removed before spraying with Trypsin and going through a second digestion incubation. (F) Lastly, slides are prepared for peptide imaging in which they are sprayed with CHCA and imaged. (G) Finally, the matrix is removed and slides are stained with H&E for histology and colocalization analysis. Abbreviations: FFPE = formalin-fixed, paraffin-embedded; SeqMSI = sequential mass spectrometry imaging; MALDI = matrix-assisted laser desorption/ionization; DAN = 1,5-diaminonaphthalene; CHCA = α-cyano-4-hydroxycinnamic acid; H&E = hematoxylin and eosin. Please click here to view a larger version of this figure.

Figure 2: Incubation chamber for PNGaseF digestion.
A piece of absorbent wipe is cut to fit the bottom of a 100 mm diameter Petri dish. Laboratory wipes are folded and rolled to form pillows that the slide can be elevated on. Please click here to view a larger version of this figure.

Figure 3: Example metabolite average mass spectrum.
(A) The full spectrum is dominated by matrix peaks around m/z 157 and clusters between m/z 300 and 350. (B) Zoomed spectrum from m/z 80 to 154 showing the wealth of metabolite peaks detected in this range. (C) Zoomed spectrum from m/z 250 to 300, a range where several free fatty acids are detected in tissue. Please click here to view a larger version of this figure.

Figure 4: Example glycan average mass spectra.
(A) An example spectrum with abundant glycan signals. These are evidenced by the decimal masses between 0.5 and 0.7. This is an example of a good PNGase F digest spectrum. (B) An example spectrum of poor glycan signal. This spectrum is dominated by peaks originating from the MALDI matrix, evidenced by decimal masses between 0.0 and 0.1. This is an example of an unsuccessful PNGase F digest spectrum. Please click here to view a larger version of this figure.

Figure 5: Example of peptide average mass spectra.
(A) An example of a spectrum with abundant peptide signal. The spectrum is robust with high-intensity peaks. (B) An example of a spectrum with poor peptide signal. The overall spectral intensity is considerably lower than A with less total peaks. Please click here to view a larger version of this figure.

Figure 6: Example MSI data from two ovarian cancer samples. (A) A metabolite (taurine) image shown in red; (B) An N-linked glycan shown in green. The cartoon indicates the composition of the sugars in the glycan, but the linkages are not known. (C) A tryptic peptide from Histone H4 shown in blue. (D) Composite image of all three ion images with insets of the H&E images. The dashed white line divides the tumor (above) and stroma (below). Abbreviations: MSI = mass spectrometry imaging; H&E = hematoxylin and eosin. Please click here to view a larger version of this figure.
Supplemental Figure S1: Instrument parameters for metabolite data acquisition. (A) m/z range, number of laser shots, and laser fluence. (B) Laser scan range and adjustment. (C) Instrument tuning parameters. Please click here to download this File.
Supplemental Figure S2: Instrument parameters for glycan data acquisition. (A) m/z range, number of laser shots, and laser fluence. (B) Laser scan range and adjustment. (C) Instrument tuning parameters. Please click here to download this File.
Supplemental Figure S3: Instrument parameters for peptide data acquisition. (A) m/z range, number of laser shots, and laser fluence. (B) Laser scan range and adjustment. (C) Instrument tuning parameters. Please click here to download this File.
The collection of sequential MSI data from a single tissue section requires careful attention to detail. There are a few steps that are absolutely crucial to achieving high-quality data. First, care should be taken if more than one slide is prepared at the same time. When placing the slides into, or moving between Coplin jars, be careful not to place two slides into the same position in the jar. This will result in inadequate solvent exposure of the tissue surface, or one slide can scrape the tissue off the other slide. Second, it is critical that the instrument be allowed to equilibrate for a minimum of 25 min when changing polarity for analysis. Over this time, the measured m/z values of molecules will drift slightly. This can be observed when spraying tune mix over this equilibration time, as the masses of the peaks will change slightly. If an image is started before the system is equilibrated, there will be mass drift of the detected peaks in the first part of the image, resulting in incorrect calibration if the calibration was performed during this settling period.
In addition, keeping the top of the Petri dish warm during the PNGaseF incubation is incredibly important. During this 2 h incubation in high humidity, it is possible for water to condense on the lid of the dish and rain down onto the tissue on the slide. If this happens, there will be noticeable areas of the tissue where the matrix will not crystallize, and no glycan signal will be observed. Images from samples with this artifact will have a pockmarked appearance. Furthermore, matrices should be filtered before loading into the sample loop of the sprayer. This helps to prevent clogging of the system. A disposable syringe filter works well for this purpose. Finally, it should be noted that when initially removing the wax from the section, the tissue will become nearly transparent after submersion in xylene. Do not be alarmed by this. It will "reappear" after it dries.
It is important to consider that the methods described herein may not be optimal for all tissue types. They have been shown to work well for most cancers, including breast, liver, and ovarian16,17,18, but some tissues, such as the brain with much higher lipid content, may not work well with these methods. It may be necessary to perform additional washing steps, such as a Carnoy's fluid wash7, if lipids still remain in the tissue after fixation. Longer incubation times for enzymes may be needed if incomplete digestion is observed. In some cases, additional passes of matrix spray may be necessary to achieve complete matrix coverage of the sample. Or fewer passes of matrix may be needed if the imaging experiments are to be carried out on a mass spectrometer with an atmospheric pressure MALDI source.
Traditionally, only a single MSI analysis has been carried out on a tissue section, or serial sections are used for different analyte types. However, this can lead to challenges when tissue is limited or when the objective is to correlate results from multiple spatial omics studies, where the goal is to analyze the same cells across multiple platforms18,20. The ability to collect multiple MSI datasets from the same tissue section helps to reduce the amount of material needed for spatial omics studies, as well as enable more facile registration of datasets; the MSI datasets are inherently registered to each other since they are collected from the same tissue section. The protocol presented here is not limited to only cancer specimens. We, and we hope others as well, are applying these workflows to a variety of tissue types and diseases. This type of workflow is greatly advancing our ability to perform meaningful multi-omics analysis for a deeper understanding of disease biology.
As with any method, there are limitations that must be considered. The extensive sample preparation of sequential imaging of the same tissue section may result in tissue loss from the slide during extended steps of solvent exposure, especially during repeat antigen retrieval of the section. If areas (or all) of the tissue are lost during the process, the datasets may not be able to be successfully co-registered to each other. Despite these challenges, we believe that this workflow will be invaluable for future clinical studies where tissue available for research is limited and/or there is a need to collect multiple datasets from the exact same cells. We also envision that future technology advancements will enable more datasets to be collected from the same tissue section, further enhancing our ability to obtain and interpret multi-omics data from cancer and other diseased tissue.
The authors have no conflicts of interest to disclose.
EHS and the University of Texas at Austin Mass Spectrometry Imaging Facility are supported by a Cancer Prevention and Research Institute of Texas Award (RP240559). This research was funded in part by the Ovarian Cancer Research Alliance (OCRA 811621 and 891490), the Sie Foundation, and the Stephanie C. Stelter Endowment Fund. This research was performed in collaboration with the Flow Cytometry and Cellular Imaging Core Facility, which is supported in part by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant P30 CA016672 and Jared Burks' NCI's Research Specialist 1 R50 CA243707-01A1.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 1,5-diaminonaphthalene | Fisher Scientific | D010125G | MALDI Matrix for metabolite imaging |
| Acetonitrile | Fisher Scientific | A955-4 | LC-MS grade solvent used for matrix preparation |
| α-cyano-4-hydroxycinnamic acid | Sigma-Aldrich | 70990-1G-F | MALDI matrix for glycan and peptide imaging |
| Ammonium Bicarbonate | Fisher Scientific | A643-500 | Buffer for enzymes |
| Ammonium Phosphate | Sigma-Aldrich | 467782-50G | Additive to reduce matrix clusters during imaging |
| Decloaking Chamber NxGen | Biocare Medical | N/A | Used for antigen retrieval of tissue |
| Ethanol | Fisher Scientific | 04-355-223 | LC-MS grade solvent used for matrix preparation and staining |
| M5 Robotic Reagent Sprayer | HTX Imaging | N/A | Used for application of enzymes and matrices to tissue |
| Methanol | Fisher Scientific | A456-4 | LC-MS grade solvent for making red phosphorus suspension |
| MS Grade Trypsin | Fisher Scientific | PI90058 | Enzyme for protein digestion |
| MTP Slide Adapter II | Bruker Daltonics | 8235380 | Adapter to insert micrscope slides into mass spectrometer |
| NanoZoomer SQ Digital Slide Scanner | Hamamatsu Corp | N/A | Used for generating digital microscopy images of stained tissue |
| Perfection V600 Flatbed Scanner | Epson | N/A | Used for generating optical image of the slide for MSI data collection |
| Petri-seal | Fisher Scientific | 50-212-518 | For sealing petri dish during enzymatic digestion |
| PNGaseF | Bulldog Bio | NZPP550LY | Enzyme for cleavage of N-linked glycans from proteins |
| Red Phosphorus | Sigma-Aldrich | 04004-250G | MALDI calibrant for both positive and negative ion mode |
| SCiLS Lab (2025b) | Bruker Daltonics | N/A | Software for MSI data visualization |
| timsTOF fleX QTOF Mass Spectrometer | Bruker Daltonics | N/A | Used for mass spectrometry data collection |
| Trifluoracetic acid | Fisher Scientific | 85183 | Matrix additive to decrease pH for positive ion mode imaging |
| Tris Base | Fisher Scientific | BP152-500 | Buffer for antigen retrieval |
| Water | Fisher Scientific | W64 | LC-MS grade solvent used for matrices, enzymes, and staining |
| WypAll X60 | Fisher Scientific | 19-413-113 | Absorbent wipe for humidified enzyme incubation |
| Xylene | Fisher Scientific | X3P-1GAL | Clearing agent for staining |
Request permission to reuse the text or figures of this JoVE article
Request Permission